SCHEMBL1316105

SCHEMBL1316105

CN(C)c1ccc(C(=O)Nc2cc(-c3ccccc3)ccc2C(=O)OC(C)(C)C)c(OCc2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 2/20 0.45
▸ NOX1 Q9Y5S8 1/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ SGMS2 Q8NHU3 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ RXRA P19793 1/20 0.40
▸ NR1H2 P55055 1/20 0.40
▸ NR1H3 Q13133 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MCL1 Q07820 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1316474 0.94 LRRK2 (0.51) LRRK2NOX1HDAC1SGMS2CYP19A1
SCHEMBL1316898 0.92 MCL1 (0.47) LRRK2HDAC1ALDH1A1SGMS2RXRA
SCHEMBL1317033 0.91 KIFC1 (0.41) LRRK2HDAC1ALDH1A1SGMS2CYP19A1
SCHEMBL1317655 0.89 GAA (0.46) LRRK2HDAC1SGMS2RXRANR1H2
SCHEMBL1317041 0.88 HDAC1 (0.43) LRRK2HDAC1ALDH1A1SGMS2RXRA
SCHEMBL1315346 0.87 HDAC1 (0.42) LRRK2HDAC1ALDH1A1SGMS2CYP19A1
SCHEMBL1316825 0.86 LRRK2 (0.52) LRRK2NOX1HDAC1SGMS2RXRA
SCHEMBL1316899 0.86 GAA (0.43) LRRK2HDAC1ALDH1A1SGMS2CYP19A1
SCHEMBL1317043 0.85 NR1H2 (0.43) LRRK2HDAC1ALDH1A1SGMS2RXRA
SCHEMBL1317653 0.84 LRRK2 (0.47) LRRK2HDAC1SGMS2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102333757-B N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD 2014-11-26 — — CN disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 — — US disclosed
CN-102333757-A N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD 2012-01-25 — — CN disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 — — US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 LRRK2 1813/4885NOX1 214/4885HDAC1 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback